ICMB
Investcorp Credit Management BDC, Inc.
There isn't enough reported data to score ICMB yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
ICMB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
ICMB's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ICMB.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ICMB PE Valuation
ICMB has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ICMB Forward outlook
There aren't enough analyst estimates for ICMB to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
ICMB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.65 | -$1.64 |
| Q2 2026 | -$1.41 | -361% |
| Q1 2026 | -$1.36 | -409% |
| Q4 2025 | -$0.61 | -233% |
| Q3 2025 | -$0.01 | -103% |
| Q2 2025 | $0.54 | +$0.82 |
| Q1 2025 | $0.44 | +$0.45 |
| Q4 2024 | $0.46 | +$0.72 |
ICMB lost $1.65 per share over the past year, and its loss has widened in each of the last five quarters.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over ICMB on earnings quality, reporting a profit while its opponent remains loss making.
ICMB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $6.8M | +9.2% |
| Q3 2022 | $6.3M | -2.8% |
| Q2 2022 | $5.8M | -12% |
| Q1 2022 | $5.9M | -1.6% |
| Q4 2021 | $6.2M | -12% |
| Q3 2021 | $6.5M | -7% |
| Q2 2021 | $6.6M | -13% |
| Q1 2021 | $6M | -32% |
MS has the stronger quarterly revenue trend. Revenue is down 88% for ICMB versus up 12% for MS.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | 222% | N/A |
| Q4 2022 | 70% | +4.1 points |
| Q3 2022 | 69% | +1.6 points |
| Q2 2022 | 73% | +8.8 points |
| Q1 2022 | 64% | -0.2 points |
| Q4 2021 | 66% | -2.4 points |
| Q3 2021 | 68% | -0.1 points |
| Q2 2021 | 64% | -2.3 points |
ICMB's operating margin was 222% last quarter, up 159 points from the same quarter a year ago, near the top of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
ICMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +125% |
| Q2 2026 | $9.3M | +$16M |
| Q1 2026 | $10.8M | +113% |
| Q4 2025 | $12M | +$19.2M |
| Q3 2025 | $1.3M | +167% |
| Q2 2025 | -$6.7M | -161% |
| Q1 2025 | $5.1M | -63% |
| Q4 2024 | -$7.2M | -576% |
ICMB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
ICMB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | +1.3K shares |
| 3 years | +0.3% | +39.8K shares |
| 5 years | +2.6% | +366K shares |
| Available history | +5.6% | +764K shares |
ICMB has 14M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over ICMB on shareholder dilution, with a more favorable share count trend.
ICMB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 7.5x | High |
| Q3 2022 | 9.1x | High |
| Q2 2022 | 8.7x | High |
| Q1 2022 | 10.1x | High |
| Q4 2021 | 9.6x | High |
| Q3 2021 | 8.9x | High |
| Q2 2021 | 9.0x | High |
| Q1 2021 | 7.4x | High |
ICMB's net debt is about 7.5 years of its operating earnings (EBITDA), down from 9.6 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ICMB.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ICMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 41.8 | Neutral |
ICMB's weekly RSI is 50 (neutral) and its Stochastic is 42 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ICMB PE vs Financial Services Sector
| Metric | ICMB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ICMB has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
ICMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.76 | 39% above |
| 20 week MA | $0.82 | 29% above |
| 50 week MA | $1.63 | 35% below |
| 100 week MA | $2.28 | 54% below |
| 200 week MA | $2.89 | 63% below |
ICMB has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 63% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over ICMB on trend strength, trading above more of its moving averages.
ICMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.75 | $4.48 | -34% |
| 2021 | $4.48 | $4.86 | +8.5% |
| 2022 | $4.86 | $3.65 | -25% |
| 2023 | $3.65 | $3.56 | -2.5% |
| 2024 | $3.56 | $3.05 | -14% |
| 2025 | $3.05 | $2.70 | -11% |
| 2026 YTD | $2.70 | $1.06 | -61% |
ICMB has finished four years in a row lower, and it's down 61% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over ICMB on returns for 2026, with the stronger performance.